Artivion Inc traded at $26.90 this Tuesday August 4th, decreasing $0.57 or 2.08 percent since the previous trading session. Looking back, over the last four weeks, Artivion lost 9.08 percent. Over the last 12 months, its price fell by 16.33 percent. Looking ahead, we forecast Artivion Inc to be priced at 26.26 by the end of this quarter and at 24.63 in one year, according to Trading Economics global macro models projections and analysts expectations.
CryoLife, Inc. (CryoLife), is a medical device company. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.